Interestingly, studies have shown increased levels of YKL-40 in very mild and mild AD-type dementia compared with control subjects [39], suggesting the validity of YKL-40 as an early biomarker in general patient AD populations and specifically in those of Hispanic ethnicity. The gene discussed is CHI3L1; the disease is dementia.